Company Filing History:
1 out of 1 
1 out of 5 
1 out of 4 Years Active: 2021
Title: **Innovator Profile: Wenju Li from Shanghai, China**
Introduction
Wenju Li is a notable inventor based in Shanghai, China, recognized for his contributions in the field of pharmaceuticals. With two patents to his name, he has made significant strides in developing compounds that target specific medical conditions.
Latest Patents
Wenju Li's latest inventions include a quinoline derivative that serves as a tyrosine kinase inhibitor. This patent outlines a quinoline derivative compound, along with its pharmaceutically acceptable salt, and details its application in creating medications for diseases associated with tyrosine kinases. His second patent reveals a salt and crystal form of compounds that work as inhibitors for FGFR and VEGFR, including a comprehensive preparation method and their medical applications.
Career Highlights
Wenju Li has contributed his expertise to organizations such as Chongqing Pharmaceutical Industrial Research Institute Co., Ltd. and Yaopharma Co., Ltd. His work in these institutions has been instrumental in advancing pharmaceutical research and development.
Collaborations
Throughout his career, Wenju Li has collaborated with fellow researchers, including Shuhui Chen and Zhengxia Chen. These partnerships have enhanced the innovation process and facilitated further advancements in their respective fields.
Conclusion
Wenju Li stands out as a significant figure in the realm of pharmaceuticals, with his innovative approaches addressing critical medical issues. His patents reflect a commitment to improving health outcomes through scientific research and exploration.